重大资产重组！A股公司公告：不停牌！

Core Viewpoint - The A-share market is witnessing a surge in major asset restructuring activities, with significant transactions announced by companies like Dongxing Medical and Fuda Alloy, indicating a revitalization of the M&A landscape following regulatory changes [2][5][9]. Group 1: Dongxing Medical - Dongxing Medical announced plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., Ltd. for cash, which is expected to constitute a major asset restructuring [2][3]. - The acquisition aligns with Dongxing Medical's strategic business development needs and aims to enhance its capabilities in the surgical medical device sector, particularly in synthetic biology [5][6]. - The transaction is still in the preliminary planning stage, with a share purchase intention agreement signed, but final terms are yet to be negotiated [5][6]. Group 2: Fuda Alloy - Fuda Alloy plans to acquire 52.61% of Zhejiang Guangda Electronic Technology Co., Ltd. for 352 million yuan, which will make it the controlling shareholder [9][10]. - The acquisition is part of Fuda Alloy's strategy to diversify its product offerings in the electronic materials sector, particularly in electronic paste products [9][10]. - Guangda Electronic has shown strong revenue growth, with projected revenues of 1.65 billion yuan in 2023 and 2.68 billion yuan in 2024, indicating a promising outlook for the acquired business [10].